| Literature DB >> 35000341 |
Conor P Lynch1, Elliot D K Cha1, Augustus J Rush Iii1, Caroline N Jadczak1, Shruthi Mohan1, Cara E Geoghegan1, Kern Singh1.
Abstract
OBJECTIVE: To assess the impact of bilateral versus unilateral interbody cages on outcomes for minimally invasive transforaminal lumbar interbody fusion (MIS TLIF) procedures.Entities:
Keywords: Instrumentation; Interbody cage; Lumbar fusion; Patient-reported outcomes; Transforaminal lumbar interbody fusion
Year: 2021 PMID: 35000341 PMCID: PMC8752695 DOI: 10.14245/ns.2142248.124
Source DB: PubMed Journal: Neurospine ISSN: 2586-6591
Patient demographics
| Demographic | Unilateral cage (n = 111) | Bilateral cages (n = 40) | p-value |
|---|---|---|---|
| Age (yr) | 53.1 ± 11.4 | 49.2 ± 10.5 | 0.058 |
| Sex | 0.538 | ||
| Female | 45 (40.5) | 14 (35.0) | |
| Male | 66 (59.5) | 26 (65.0) | |
| Body mass index (kg/m2) | 0.554 | ||
| < 30 | 55 (49.6) | 22 (55.0) | |
| ≥ 30 | 56 (50.5) | 18 (45.0) | |
| Smoking status | 0.339 | ||
| Nonsmoker | 93 (83.8) | 36 (90.0) | |
| Smoker | 18 (16.2) | 4 (10.0) | |
| Diabetes | 0.041[ | ||
| Nondiabetic | 95 (85.9) | 39 (97.5) | |
| Diabetic | 16 (14.4) | 2.5 (1 | |
| ASA PS classification grade | 2.1 ± 0.5 | 2.0 ± 0.5 | 0.242 |
| CCI score | 2.0 ± 1.5 | 1.2 ± 1.1 | 0.003[ |
| Insurance | 0.010[ | ||
| Medicare/medicaid | 11 (9.9) | 0 (0) | |
| Workers’ compensation | 45 (40.5) | 10 (25.0) | |
| Private | 55 (49.6) | 30 (75.0) |
Values are presented as mean±standard deviation or number (%).
ASA PS, American Society of Anesthesiologists physical status; CCI, Charlson Comorbidity Index; SD, standard deviation.
p<0.05, statistical significance.
Perioperative characteristics
| Characteristic | Unilateral cage (n = 111) | Bilateral cages (n = 40) | p-value |
|---|---|---|---|
| Spinal pathology | |||
| Recurrent herniated nucleus pulposus | 9 (8.1) | 2 (5.0) | 0.517 |
| Degenerative spondylolisthesis | 57 (51.4) | 9 (22.5) | 0.002[ |
| Isthmic spondylolisthesis | 24 (21.6) | 28 (70.0) | < 0.001[ |
| Fusion level | 0.003[ | ||
| L3/L4 | 3 (2.7) | 0 (0) | |
| L4/L5 | 59 (53.2) | 10 (25.0) | |
| L5/S1 | 49 (44.1) | 30 (75.0) | |
| Bone graft | 0.069 | ||
| BMP-2 | 97 (87.4) | 34 (85.0) | |
| Iliac crest bone graft | 1 (0.9) | 3 (7.5) | |
| Other[ | 13 (11.7) | 3 (7.5) | |
| Operative time (min) | 138.3 ± 33.3 | 143.2 ± 32.1 | 0.429 |
| Estimated blood loss (mL) | 64.0 ± 32.0 | 66.9 ± 51.4 | 0.680 |
| Length of stay (hr) | 56.3 ± 32.1 | 43.2 ± 21.8 | 0.022[ |
| Arthrodesis by 1 year[ | 0.035[ | ||
| Nonunion | 12 (11.0) | 0 (0) | |
| Solid fusion | 97 (89.0) | 37 (100) |
Values are presented as number (%) or mean±standard deviation.
BMP-2, bone morphogenic protein-2.
p<0.05, statistical significance.
Other synthetic bone graft substitute+local bone graft without the use of BMP-2 or iliac crest bone graft.
Arthrodesis status was not able to be assessed for 5 patients due to unavailable postoperative computed tomography scans.
Patient-reported outcomes
| PROM | Unilateral cage | Bilateral cages | p-value[ | p-value[ |
|---|---|---|---|---|
| VAS back | ||||
| Preoperative | 6.8 ± 2.1 | 6.8 ± 2.4 | 0.932 | |
| 6 Weeks (Δ) | 2.8 ± 2.7 | 2.4 ± 3.4 | 0.487 | 0.551 |
| 12 Weeks (Δ) | 3.0 ± 2.8 | 3.6 ± 3.0 | 0.282 | 0.888 |
| 6 Months (Δ) | 3.2 ± 2.9 | 4.0 ± 3.1 | 0.226 | 0.277 |
| 1 Year (Δ) | 3.1 ± 2.4 | 3.9 ± 3.1 | 0.352 | 0.412 |
| 2 Years (Δ) | 3.7 ± 3.1 | 2.9 ± 4.6 | 0.606 | 0.212 |
| VAS leg | ||||
| Preoperative | 6.1 ± 2.5 | 4.6 ± 3.2 | 0.017[ | |
| 6 Weeks (Δ) | 3.1 ± 3.4 | 2.0 ± 4.1 | 0.214 | 0.995 |
| 12 Weeks (Δ) | 3.0 ± 2.8 | 2.3 ± 3.5 | 0.308 | 0.805 |
| 6 Months (Δ) | 3.3 ± 2.8 | 2.0 ± 3.1 | 0.084 | 0.393 |
| 1 Year (Δ) | 3.9 ± 2.9 | 2.8 ± 2.5 | 0.199 | 0.054 |
| 2 Years (Δ) | 3.8 ± 3.1 | 3.0 ± 3.4 | 0.547 | 0.380 |
| ODI | ||||
| Preoperative | 45.1 ± 17.2 | 39.6 ± 15.6 | 0.145 | |
| 6 Weeks (Δ) | 7.9 ± 17.4 | 4.9 ± 21.7 | 0.511 | 0.259 |
| 12 Weeks (Δ) | 13.2 ± 16.3 | 17.4 ± 17.8 | 0.296 | 0.615 |
| 6 Months (Δ) | 17.7 ± 15.3 | 18.3 ± 22.2 | 0.888 | 0.930 |
| 1 Year (Δ) | 19.0 ± 17.5 | 18.4 ± 14.6 | 0.915 | 0.412 |
| 2 Years (Δ) | 25.8 ± 23.5 | 8.2 ± 29.6 | 0.118 | 0.026[ |
| SF-12 PCS | ||||
| Preoperative | 30.0 ± 9.0 | 34.9 ± 12.4 | 0.045[ | |
| 6 Weeks (Δ) | 0.9 ± 9.4 | -0.4 ± 8.4 | 0.642 | 0.666 |
| 12 Weeks (Δ) | 7.2 ± 9.4 | 10.8 ± 11.4 | 0.307 | 0.611 |
| 6 Months (Δ) | 9.8 ± 12.0 | 12.9 ± 12.4 | 0.469 | 0.663 |
| 1 Year (Δ) | 13.6 ± 9.8 | 9.8 ± 8.3 | 0.212 | 0.170 |
| 2 Years (Δ) | 11.9 ± 11.3 | 7.4 ± 11.1 | 0.289 | 0.253 |
| PROMIS-PF | ||||
| Preoperative | 34.0 ± 5.6 | 37.0 ± 4.7 | 0.165 | |
| 6 Weeks (Δ) | 1.4 ± 5.3 | -0.2 ± 6.2 | 0.556 | 0.108 |
| 12 Weeks (Δ) | 2.9 ± 6.7 | 7.4 ± 5.5 | 0.120 | 0.434 |
| 6 Months (Δ) | 8.5 ± 9.2 | 11.2 ± 5.0 | 0.469 | 0.436 |
| 1 Year (Δ) | 7.2 ± 5.4 | 13.8 ± 8.6 | 0.091 | 0.423 |
| 2 Years (Δ) | 3.7 ± 4.0 | 13.7 ± 4.4 | 0.001[ | 0.060 |
Values are presented as mean±standard deviation.
PROM, Patient-Reported Outcome Measures; VAS, visual analogue scale; ODI, Oswestry Disability Index; SF-12 PCS, 12-item Short Form health survey physical composite score; PROMIS-PF, Patient-Reported Outcome Measurement Information System physical function.
p<0.05, statistical significance.
p-values calculated using Student t-test to compare mean preoperative scores and mean postoperative improvement between groups.
p-values calculated using 1-way analysis of covariance to compare mean postoperative improvement between groups while accounting for significant covariates.
Achievement of MCID
| PROM | Unilateral cage | Bilateral cages | OR (95% CI) | p-value[ | p-value[ |
|---|---|---|---|---|---|
| VAS back | |||||
| 6 Weeks | 54 (55.1) | 160 (50.0) | 0.8 (0.4–1.8) | 0.615 | 0.662 |
| 12 Weeks | 49 (55.7) | 20 (62.5) | 1.3 (0.6–3.0) | 0.505 | 0.749 |
| 6 Months | 53 (63.9) | 19 (67.9) | 1.2 (0.5–3.0) | 0.701 | 0.510 |
| 1 Year | 15 (62.5) | 12 (66.7) | 1.2 (0.3–4.3) | 0.780 | 0.226 |
| 2 Years | 9 (60.0) | 6 (60.0) | 1.0 (0.2–5.2) | 0.999 | 0.996 |
| Overall | 73 (73.0) | 26 (74.3) | 1.1 (0.4–2.6) | 0.882 | 0.208 |
| VAS leg | |||||
| 6 Weeks | 16 (36.4) | 9 (30.0) | 0.8 (0.3–2.0) | 0.570 | 0.943 |
| 12 Weeks | 14 (32.6) | 8 (26.7) | 0.8 (0.3–2.1) | 0.590 | 0.428 |
| 6 Months | 13 (32.5) | 5 (18.5) | 0.5 (0.1–1.5) | 0.210 | 0.361 |
| 1 Year | 9 (37.5) | 4 (21.1) | 0.4 (0.2–1.8) | 0.249 | 0.020[ |
| 2 Years | 4 (33.3) | 3 (27.3) | 0.8 (0.1–4.5) | 0.753 | - |
| Overall | 26 (57.8) | 110 (33.3) | 0.4 (0.1–0.9) | 0.035[ | 0.077 |
| ODI | |||||
| 6 Weeks | 22 (46.8) | 14 (46.7) | 1.0 (0.4–2.5) | 0.990 | 0.219 |
| 12 Weeks | 26 (59.1) | 21 (70.0) | 1.6 (0.6–4.3) | 0.340 | 0.892 |
| 6 Months | 31 (75.6) | 20 (74.1) | 0.9 (0.3–2.8) | 0.886 | 0.573 |
| 1 Year | 16 (64.0) | 14 (73.7) | 1.6 (0.4–5.8) | 0.496 | 0.962 |
| 2 Years | 9 (69.3) | 8 (72.7) | 1.2 (0.2–7.0) | 0.851 | 0.544 |
| Overall | 39 (81.3) | 27 (79.4) | 0.9 (0.3–2.7) | 0.836 | 0.699 |
| SF-12 PCS | |||||
| 6 Weeks | 9 (42.9) | 8 (42.1) | 1.0 (0.3–3.4) | 0.962 | 0.898 |
| 12 Weeks | 11 (57.9) | 13 (72.2) | 1.9 (0.5–7.5) | 0.364 | 0.835 |
| 6 Months | 15 (75.0) | 11 (73.3) | 0.9 (0.2–4.2) | 0.911 | 0.745 |
| 1 Year | 18 (85.7) | 15 (79.0) | 0.6 (0.1–3.2) | 0.576 | 0.850 |
| 2 Years | 12 (75.0) | 9 (69.2) | 0.8 (0.1–3.8) | 0.730 | 0.796 |
| Overall | 25 (80.7) | 22 (84.6) | 1.3 (0.3–5.3) | 0.695 | 0.807 |
| PROMIS-PF | |||||
| 6 Weeks | 3 (37.5) | 3 (25.0) | 0.6 (0.1–3.9) | 0.552 | 0.995 |
| 12 Weeks | 3 (42.9) | 10 (76.9) | 4.4 (0.6–32.1) | 0.139 | 0.878 |
| 6 Months | 3 (50.0) | 8 (88.9) | 8.0 (0.6–110.3) | 0.120 | 0.149 |
| 1 Year | 5 (71.4) | 10 (90.9) | 4.0 (0.3–55.5) | 0.301 | 0.585 |
| 2 Years | 3 (50.0) | 8 (100) | - | - | - |
| Overall | 7 (77.8) | 14 (87.5) | 2.0 (0.2–17.3) | 0.529 | 0.460 |
Values are presented as number (%).
MCID, minimum clinically important difference; PROM, Patient-Reported Outcome Measures; OR, odds ratio; CI, confidence interval; VAS, visual analogue scale; ODI, Oswestry Disability Index; SF-12 PCS, 12-item Short Form health survey physical composite score; PROMIS-PF, Patient-Reported Outcome Measurement Information System physical function.
p<0.05, statistical significance.
p-values calculated using logistic regression to assess rates of MCID achievement between groups.
p-values calculated using multiple logistic regression to assess rates of MCID achievement between groups while accounting for significant covariates.